Supply Chain

The average ASC spends a whopping $230,000 on supplies and keeps $100,000 to $120,000 of inventory on hand per surgical suite. Having so much cash tied up in inventory is presenting new challenges for ASCs as they deal with external…

The worldwide orthopedic devices market is projected to reach approximately $43.1 billion by 2024, according to Amruta Joshi, a senior technical writer at Grand View Research.

Global Healthcare Exchange recognized Cook Medical's vice president of healthcare solutions, Dave Reed, as a leader in healthcare operations.

Physicians at ASCs are often invested in the facility, with financial ramifications for decisions they make. That investment can make it easier for supply chain leaders to build rapport with physicians and affect change, according to Quorum Purchasing Advantage Vice…

MedicalDesign & Outsourcing took a deep dive into the Minnesota medical device development scene to examine what some consider the next hotbed of medical device development.

Johnson and Johnson's DePuy Synthes Products signed off on an agreement to acquire Medical Enterprises Distribution's assets, including the automated ME1000 Surgical Impactor for use in hip replacement procedures.

President Donald Trump unveiled a proposal May 11 to slash the prices of pharmaceutical drugs, The New York Times reports.

McKesson Medical-Surgical offers a comprehensive portfolio of products and services for ASCs, including custom procedure trays, IV therapy and pharmaceuticals.

The FDA added EpiPen to its drug shortages list, after manufacturing delays disrupted available supply, U.S. News & World Report reports.

Takeda Pharmaceutical investors may have been skeptical of Takeda's $62 billion acquisition of Shire at first, but Bloomberg believes they'll eventually come around.